A Patient-Centric Platform Trial for Precision Oncology

Description

XCELSIOR is a non-interventional data registry. Information about treatments, treatment decisions and rationale, and patient outcomes including safety and effectiveness of anti-cancer therapy and associated supportive care will be collected for analysis.

Conditions

Oncology

Talk to us

Study Overview

On this page

Study Details

Study overview

XCELSIOR is a non-interventional data registry. Information about treatments, treatment decisions and rationale, and patient outcomes including safety and effectiveness of anti-cancer therapy and associated supportive care will be collected for analysis.

xCures/CancerCommons Enhanced Learning Treatment Selection and Analysis With Outcomes Research (XCELSIOR) Study: A Patient-Centric Platform Trial for Precision Oncology

A Patient-Centric Platform Trial for Precision Oncology

Condition
Oncology
Intervention / Treatment

-

Contacts and Locations

Los Altos

Cancer Commons, Los Altos, California, United States, 94022

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Both male and female patients with known or suspected recalcitrant or advanced cancer are eligible to enroll through the Cancer Commons Website
  • * Patients with any performance status, comorbidity or disease severity are eligible
  • * Patients or their legally-authorized representative must be willing and able to provide written, informed consent (and assent, if applicable)
  • * Patients must be a resident of or receiving care within the United States or US territories.

Ages Eligible for Study

0 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

xCures,

Mark Shapiro, PRINCIPAL_INVESTIGATOR, xCures / Cancer Commons

Study Record Dates

2026-01